News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
217,671 Results
Type
Article (9574)
Company Profile (20)
Press Release (208074)
Multimedia
Podcasts (12)
Webinars (9)
Section
Business (80297)
Career Advice (458)
Deals (11855)
Drug Delivery (27)
Drug Development (24653)
Employer Resources (54)
FDA (4648)
Job Trends (4412)
News (120765)
Policy (9109)
Tag
Academia (721)
Accelerated approval (7)
Adcomms (12)
Allergies (40)
Alliances (14778)
ALS (40)
Alzheimer's disease (529)
Antibody-drug conjugate (ADC) (98)
Approvals (4808)
Artificial intelligence (171)
Autoimmune disease (33)
Automation (7)
Bankruptcy (75)
Best Places to Work (3722)
BIOSECURE Act (3)
Biosimilars (56)
Biotechnology (14)
Bladder cancer (35)
Brain cancer (11)
Breast cancer (147)
Cancer (1459)
Cardiovascular disease (103)
Career advice (389)
Career pathing (11)
CAR-T (55)
CDC (4)
Celiac Disease (1)
Cell therapy (175)
Cervical cancer (13)
Clinical research (21588)
Collaboration (477)
Compensation (68)
Complete response letters (10)
COVID-19 (733)
CRISPR (17)
C-suite (283)
Cystic fibrosis (30)
Data (1972)
Decentralized trials (1)
Denatured (6)
Depression (16)
Diabetes (140)
Diagnostics (2249)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (73)
Drug pricing (31)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (45577)
Editorial (8)
Employer branding (8)
Employer resources (51)
Events (31214)
Executive appointments (309)
FDA (5559)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (304)
Gene editing (36)
Generative AI (17)
Gene therapy (128)
GLP-1 (236)
Government (1142)
Grass and pollen (2)
Guidances (224)
Healthcare (5533)
HIV (23)
Huntington's disease (9)
IgA nephropathy (20)
Immunology and inflammation (42)
Immuno-oncology (16)
Indications (41)
Infectious disease (812)
Inflammatory bowel disease (59)
Inflation Reduction Act (1)
Influenza (41)
Intellectual property (81)
Interviews (67)
IPO (5970)
IRA (7)
Job creations (873)
Job search strategy (352)
JPM (10)
Kidney cancer (10)
Labor market (10)
Layoffs (94)
Leadership (8)
Legal (1747)
Liver cancer (24)
Longevity (2)
Lung cancer (253)
Lymphoma (142)
Machine learning (15)
Management (20)
Manufacturing (201)
MASH (32)
Medical device (4617)
Medtech (4636)
Mergers & acquisitions (6137)
Metabolic disorders (284)
Multiple sclerosis (48)
Neurodegenerative disease (89)
Neuropsychiatric disorders (8)
Neuroscience (847)
NextGen: Class of 2026 (1695)
Non-profit (1250)
Now hiring (5)
Obesity (121)
Opinion (57)
Ovarian cancer (41)
Pain (35)
Pancreatic cancer (66)
Parkinson's disease (103)
Partnered (7)
Patents (107)
Patient recruitment (110)
Peanut (23)
People (20505)
Pharmaceutical (10)
Pharmacy benefit managers (1)
Phase 1 (5856)
Phase 2 (9210)
Phase 3 (8180)
Pipeline (1878)
Policy (42)
Postmarket research (880)
Preclinical (2385)
Press Release (16)
Prostate cancer (81)
Psychedelics (4)
Radiopharmaceuticals (98)
Rare diseases (170)
Real estate (1615)
Recruiting (23)
Regulatory (7408)
Reports (13)
Research institute (709)
Resumes & cover letters (64)
Rett syndrome (6)
RSV (20)
Schizophrenia (43)
Series A (56)
Series B (43)
Service/supplier (1)
Sickle cell disease (19)
Spinal muscular atrophy (28)
Sponsored (13)
Startups (861)
Stomach cancer (5)
Supply chain (22)
Tariffs (16)
The Weekly (6)
Vaccines (288)
Venture capital (20)
Weight loss (55)
Women's health (19)
Worklife (5)
Date
Today (68)
Last 7 days (190)
Last 30 days (623)
Last 365 days (8800)
2026 (920)
2025 (8752)
2024 (10307)
2023 (12391)
2022 (17011)
2021 (18191)
2020 (17026)
2019 (14647)
2018 (11295)
2017 (11604)
2016 (10647)
2015 (13018)
2014 (9123)
2013 (7068)
2012 (7752)
2011 (8147)
2010 (7101)
Location
Africa (274)
Alabama (12)
Arizona (60)
Arkansas (1)
Asia (15476)
Australia (2843)
California (2786)
Canada (960)
China (446)
Colorado (140)
Connecticut (120)
Delaware (82)
Europe (38342)
Florida (492)
Georgia (98)
Hawaii (2)
Idaho (25)
Illinois (234)
India (22)
Indiana (163)
Iowa (3)
Japan (181)
Kansas (27)
Kentucky (9)
Louisiana (16)
Maine (51)
Maryland (376)
Massachusetts (1982)
Michigan (107)
Minnesota (183)
Missouri (39)
Montana (12)
Nebraska (6)
Nevada (55)
New Hampshire (28)
New Jersey (1076)
New Mexico (5)
New York (747)
North Carolina (417)
North Dakota (2)
Northern California (1310)
Ohio (75)
Oklahoma (5)
Oregon (6)
Pennsylvania (611)
Puerto Rico (7)
Rhode Island (9)
South America (451)
South Carolina (21)
Southern California (1188)
Tennessee (26)
Texas (402)
United States (10597)
Utah (94)
Virginia (37)
Washington D.C. (14)
Washington State (222)
West Virginia (1)
Wisconsin (34)
Wyoming (2)
217,671 Results for "janssen cilag international nv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
February 12, 2026
·
11 min read
Press Releases
Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
February 10, 2026
·
8 min read
Press Releases
Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award
January 8, 2026
·
4 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Press Releases
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
January 20, 2026
·
1 min read
Press Releases
Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures
January 13, 2026
·
2 min read
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (“Janssen PMP”) are pleased to announce a significant expansion to their existing Exclusive Evaluation and Option Agreement
September 6, 2023
·
9 min read
Press Releases
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2
January 14, 2026
·
11 min read
Press Releases
Vivoryon Therapeutics N.V. to Present at Upcoming Conferences
November 3, 2025
·
3 min read
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease
Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.
May 1, 2024
·
14 min read
1 of 21,768
Next
